Water soluble cellulose etherified derivatives styptic materials
    1.
    发明申请
    Water soluble cellulose etherified derivatives styptic materials 有权
    水溶性纤维素醚化衍生物苯乙烯类物质

    公开(公告)号:US20060014721A1

    公开(公告)日:2006-01-19

    申请号:US10476559

    申请日:2001-04-30

    IPC分类号: A61K31/716 C08B11/12

    摘要: The present invention relates to hemostatic materials made of water-soluble cellulose ether derivatives, such as methylcellulose, ethylcellulose, hydroxyethylcellulose, and pharmaceutically acceptable salts of carboxymethylcellulose, especially to hemostatic materials made of water-soluble cellulose ether derivatives capable of being absorbed in live body. The present invention also relates to the use of water-soluble cellulose hemostatic materials for the preparation of internal and external hemostatic articles and pharmaceutical compositions, and hemostatic articles and pharmaceutical compositions thereof.

    摘要翻译: 本发明涉及由水溶性纤维素醚衍生物如甲基纤维素,乙基纤维素,羟乙基纤维素和羧甲基纤维素的药学上可接受的盐形成的止血材料,特别是由能够吸收在活体中的水溶性纤维素醚衍生物制成的止血材料 。 本发明还涉及水溶性纤维素止血材料用于制备内部和外部止血制品和药物组合物以及止血制品及其药物组合物的用途。

    Water soluble cellulose etherified derivatives styptic materials
    2.
    发明授权
    Water soluble cellulose etherified derivatives styptic materials 有权
    水溶性纤维素醚化衍生物苯乙烯类物质

    公开(公告)号:US07262181B2

    公开(公告)日:2007-08-28

    申请号:US10476559

    申请日:2001-04-30

    IPC分类号: A61K31/717 C08B11/12

    摘要: The present invention relates to hemostatic materials made of water-soluble cellulose ether derivatives, such as methylcellulose, ethylcellulose, hydroxyethylcellulose, and pharmaceutically acceptable salts of carboxymethylcellulose, especially to hemostatic materials made of water-soluble cellulose ether derivatives capable of being absorbed in live body. The present invention also relates to the use of water-soluble cellulose hemostatic materials for the preparation of internal and external hemostatic articles and pharmaceutical compositions, and hemostatic articles and pharmaceutical compositions thereof.

    摘要翻译: 本发明涉及由水溶性纤维素醚衍生物如甲基纤维素,乙基纤维素,羟乙基纤维素和羧甲基纤维素的药学上可接受的盐形成的止血材料,特别是由能够吸收在活体中的水溶性纤维素醚衍生物制成的止血材料 。 本发明还涉及水溶性纤维素止血材料用于制备内部和外部止血制品和药物组合物以及止血制品及其药物组合物的用途。

    Compounds acting at the centrosome
    6.
    发明申请
    Compounds acting at the centrosome 审中-公开
    作用于中心体的化合物

    公开(公告)号:US20060167106A1

    公开(公告)日:2006-07-27

    申请号:US11283570

    申请日:2005-11-18

    IPC分类号: A61K31/16 C07C327/40

    摘要: The present invention relates to compounds, and methods utilizing compounds, which exhibit one or more of the following properties: i) disrupts organization of an actin cytoskeleton of a cell; ii) disrupts organization of a microtubule network of a cell; iii) induces accumulation of tubulin at centrosomes but does not induce accumulation of tubulin in a nucleus of a cell; iv) induces accumulation of tubulin at centrosomes at a concentration of 500 nM or less within four hours; v) induces accumulation of Hsp70 and has weak-to-moderate proteasome inhibitory activity; and vi) does not have proteasome inhibitory activity when assayed on purified proteasomes.

    摘要翻译: 本发明涉及化合物和利用化合物的方法,其具有以下一个或多个性质:i)破坏细胞的肌动蛋白细胞骨架的组织; ii)破坏细胞微管网络的组织; iii)诱导微管蛋白在中心体的积累,但不诱导微管蛋白在细胞核中的积累; iv)在四小时内以500nM或更小的浓度诱导中心体上的微管蛋白积累; v)诱导Hsp70的积累并具有弱至中度的蛋白酶体抑制活性; 和vi)在纯化的蛋白酶体上测定时不具有蛋白酶体抑制活性。

    Flow Control Line Management Apparatus
    9.
    发明申请
    Flow Control Line Management Apparatus 有权
    流量控制线管理装置

    公开(公告)号:US20120283630A1

    公开(公告)日:2012-11-08

    申请号:US13460071

    申请日:2012-04-30

    IPC分类号: A61M5/168

    摘要: A line management apparatus for managing multiple IV lines connected in a Y fitting or multi-way fitting provides for flow sensing and for electronic control of flow in the multiple lines. The line management apparatus may be used independently as a precise gravity feed IV system or may provide for use in combination with an infusion pump to ensure proper delivery of multiple solutions without blending of the two.

    摘要翻译: 用于管理以Y拟合或多路连接方式连接的多条IV线的线路管理装置提供用于多条线路中的流量检测和电子控制的线路管理装置。 线路管理装置可以独立地用作精确的重力馈送IV系统,或者可以提供与输注泵组合使用,以确保多个解决方案的适当传递,而不会混合两者。

    Method for manufacturing carbon nanocoils
    10.
    发明授权
    Method for manufacturing carbon nanocoils 有权
    制造碳纳米线的方法

    公开(公告)号:US06558645B2

    公开(公告)日:2003-05-06

    申请号:US09901991

    申请日:2001-07-10

    IPC分类号: D01F912

    摘要: A method for manufacturing carbon nanocoils which are grown by winding carbon atoms in a helical configuration and which have an external diameter of 1000 nm or less, the method comprising the steps of: placing an indium-tin-iron type catalyst inside a reactor, heating an area around the catalyst to a temperature equal to or greater than temperature at which hydrocarbon used as a raw material is broken down by an action of the catalyst, causing hydrocarbon gas to flow through the reactor so that the gas contacts the catalyst, and allowing carbon nanocoils to grow on a surface of the catalyst while the hydrocarbon is broken down in the vicinity of the catalyst. The indium-tin-iron type catalyst may be obtained by: a mixed catalyst of indium oxide and tin oxide, and a thin film of iron which is formed on a surface of this mixed catalyst.

    摘要翻译: 一种制造碳纳米薄膜的方法,其通过将螺旋形状的碳原子缠绕并且具有1000nm或更小的外径而生长,所述方法包括以下步骤:将铟 - 锡 - 铁型催化剂置于反应器内,加热 催化剂周围的区域达到等于或大于用作原料的烃的温度的温度,通过催化剂的作用被分解,导致烃气体流过反应器,使得气体与催化剂接触,并允许 碳纳米薄膜在催化剂表面生长,同时烃在催化剂附近分解。 铟 - 锡 - 铁型催化剂可以通过以下方法获得:氧化铟和氧化锡的混合催化剂和形成在该混合催化剂的表面上的铁的薄膜。